Form 4: Clearwater Analytics CFO Exercises Options, Sells Shares
Insider Transaction Report
Clearwater Analytics' Chief Financial Officer, James S. Cox, reported exercising stock options and selling a portion of his Class A Common Stock, including shares for tax obligations, on December 15, 2025.
Summary
- James S. Cox, CFO of Clearwater Analytics Holdings, Inc. (CWAN), reported multiple transactions on December 15, 2025.
- He acquired a total of 16,039 Class A Common Stock shares by exercising stock options at an exercise price of $4.4 per share.
- Concurrently, he disposed of 11,275 Class A Common Stock shares through sales under a Rule 10b5-1 trading plan.
- Additionally, 9,764 Class A Common Stock shares were disposed of to cover tax withholding obligations related to the option exercises.
- Following these transactions, Cox beneficially owns 328,983 Class A Common Stock shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The exercise of options indicates value realization, and the sales are largely expected as part of executive compensation management and tax obligations, often pre-planned under a 10b5-1 plan. There's no indication of distress or unusual activity, but also no new positive news about the company itself.
Positives
- The CFO exercised stock options, indicating a realization of value from previously granted equity.
- The exercise price of $4.4 is significantly lower than the sale prices ($21.3421, $21.88, $21.34), indicating a substantial gain on the exercised options.
- The discretionary sales were executed under a pre-arranged Rule 10b5-1 trading plan, suggesting planned and not reactive selling.
Negatives
- The CFO sold a significant number of shares (11,275 shares in discretionary sales plus 9,764 for tax withholding), which could be interpreted as a reduction in direct ownership.
- While some sales were for tax obligations, other sales were discretionary under a 10b5-1 plan, reducing the CFO's direct stake.
Future Outlook
NA
Industry Context
This Form 4 filing reflects routine insider transactions for a Chief Financial Officer at a publicly traded financial technology company. Such transactions are common for executives managing their equity compensation and personal financial planning, often through pre-arranged trading plans like Rule 10b5-1 plans. It does not provide specific insights into broader industry trends for financial software or investment management platforms.
Stakeholder Impact
- Shareholders: The sale of shares by a CFO, even if pre-planned, could be viewed neutrally or slightly negatively by some investors as a reduction in direct insider ownership, though the overall beneficial ownership remains substantial. The exercise of options demonstrates the value of equity compensation.
Key Dates
| Date | Description |
|---|---|
| 2020-01-21 | Vesting date for 180,000 stock option shares. |
| 2020-11-02 | Vesting date for 297,000 stock option shares. |
| 2021-03-05 | Vesting date for 105,750 stock option shares. |
| 2022-01-01 | Vesting date for 105,750 stock option shares. |
| 2023-01-01 | Vesting date for 105,750 stock option shares. |
| 2024-01-01 | Vesting date for 105,750 stock option shares. |
| 2024-03-11 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 2025-12-15 | Date of earliest transaction (stock option exercises and share sales). |
| 2025-12-17 | Signature date of the Form 4 filing. |
| 2029-05-20 | Expiration date for stock options. |
Recommendation
holdThis Form 4 filing details routine insider transactions by the CFO, involving the exercise of stock options and subsequent sales of shares, some for tax purposes and others under a pre-arranged 10b5-1 plan. These transactions are common for executives managing their equity compensation and do not provide new material information about the company's operational performance, strategic direction, or financial health. Therefore, based solely on this filing, there is no new information to warrant a change in investment thesis, and a 'hold' recommendation is appropriate.
Keywords
Clearwater Analytics, CWAN, Form 4, Insider Trading, Stock Options, Share Sale, CFO, James S. Cox, Equity Compensation, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.